Progressive bevacizumab-associated renal thrombotic microangiopathy*

Vascular endothelial growth factor (VEGF) is integral to the integrity of the glomerular filtration barrier. Bevacizumab is a humanized monoclonal antibody directed against VEGF with expanding clinical applications for metastatic solid tumours. We describe a case of a 61-year-old female with ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales: Uy, Alice L., Simper, Novae B., Champeaux, Anne L., Perkins, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421476/
https://www.ncbi.nlm.nih.gov/pubmed/25949282
http://dx.doi.org/10.1093/ndtplus/sfn168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421476/
https://www.ncbi.nlm.nih.gov/pubmed/25949282
http://dx.doi.org/10.1093/ndtplus/sfn168

Ejemplares similares